To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF580andZNF581andCCDC106TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
485 supporting clones for gene ZNF580andZNF581andCCDC106 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CK818883 Islets of Langerhans, Pancreas .a 1 to 558 1 to 558   tiling clone,   558/558
(100 %)
1 diff
(99.9 %id)
BM126294 Islets of Langerhans, Pancreas .a 17 to 586 1 to 571       571/571
(100 %)
13 diff
(97.8 %id)
AL359054   .a 48 to 1261 11 to 1221   tiling clone, AAA   1211/1221
(99 %)
4 diff
(99.7 %id)
BQ673121 epidermoid carcinoma, cell line, salivary gland .a 108 to 436 1 to 326       326/1103
(29 %)
7 diff
(99.4 %id)
DA386187 thalamus .a 121 to 686 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BM460140 leiomyosarcoma, uterus .a 125 to 689 25 to 593       569/1207
(47 %)
8 diff
(99.4 %id)
CF128217 Chondrosarcoma Lung Metastasis cell lines, lung .a 125 to 397 22 to 294       273/295
(92 %)
5 diff
(98.4 %id)
NM_207115.1   .a 131 to 1261 1 to 1131   RefSeq, AAA   1131/1131
(100 %)
0 diff
(100 %id)
BM463757 leiomyosarcoma, uterus .a 140 to 657 1 to 515       515/1075
(47 %)
19 diff
(98.3 %id)
CR609067 T cells (Jurkat cell line) Cot10-normalized .a 143 to 1242 1 to 1100   tiling clone,   1100/1100
(100 %)
0 diff
(100 %id)
BQ278034 ovary, teratocarcinoma, cell line .a 145 to 789 1 to 648       648/1182
(54 %)
27 diff
(97.8 %id)
BU845411 ovary, teratocarcinoma, cell line .a 145 to 878 1 to 746       746/950
(78 %)
32 diff
(96.7 %id)
BU855208 ovary, teratocarcinoma, cell line .a 145 to 906 1 to 762       762/902
(84 %)
9 diff
(99.1 %id)
AL559437 T cells from T cell leukemia .a 148 to 685 6 to 537   fully sequenced,   532/537
(99 %)
2 diff
(99.7 %id)
BM544713 brain, hippocampus .a 151 to 786 7 to 646       640/1239
(51 %)
13 diff
(99.0 %id)
BQ888961 epidermoid carcinoma, cell line, salivary gland .a 152 to 626 1 to 475       475/1088
(43 %)
10 diff
(99.1 %id)
BQ674160 epidermoid carcinoma, cell line, salivary gland .a 152 to 611 1 to 460       460/1051
(43 %)
14 diff
(98.7 %id)
TI_44343439   .a 153 to 786 125 to 775       651/1032
(63 %)
40 diff
(96.2 %id)
CR616291 B cells (Ramos cell line) Cot 25-normalized .a 155 to 1230 1 to 1076       1076/1076
(100 %)
0 diff
(100 %id)
AL560584 B cells from Burkitt lymphoma .a 155 to 695 1 to 532   fully sequenced,   532/532
(100 %)
25 diff
(95.4 %id)
BI667481 brain, hypothalamus .a 155 to 786 1 to 649       649/906
(71 %)
45 diff
(95.1 %id)
BM926205 brain .a 170 to 670 14 to 517       504/1197
(42 %)
6 diff
(99.5 %id)
BX339579 Placenta Cot 25-normalized .a 179 to 904 1 to 724       724/724
(100 %)
5 diff
(99.4 %id)
BM563028 brain, medulla .a 181 to 1047 1 to 876       876/1073
(81 %)
27 diff
(97.5 %id)
AK314888   .a 184 to 819 1 to 636       636/636
(100 %)
1 diff
(99.9 %id)
DA004467   .a 185 to 757 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BY797763 eye .a 190 to 681 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BU173552 melanotic melanoma, cell line, skin .a 221 to 819 1 to 600       600/891
(67 %)
10 diff
(98.9 %id)
BU179609 melanotic melanoma, cell line, skin .a 221 to 993 1 to 775       775/935
(82 %)
17 diff
(98.2 %id)
BQ680837 melanotic melanoma, cell line, skin .a 221 to 609 1 to 389       389/1367
(28 %)
9 diff
(99.4 %id)
EC509210 Prostate .a 299 to 377 1 to 78       78/92
(84 %)
2 diff
(97.9 %id)
EC524406 Prostate .a 299 to 377 1 to 78       78/92
(84 %)
2 diff
(97.9 %id)
CV023969 mixed .a 301 to 672 1 to 373       373/373
(100 %)
23 diff
(93.9 %id)
BI085012 epidermoid carcinoma, cell line, salivary gland .a 361 to 1213 843 to 2       842/877
(96 %)
0 diff
(100 %id)
CN363271 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 372 to 877 1 to 507       507/514
(98 %)
3 diff
(99.5 %id)
BQ430588 epithelioid carcinoma, Pancreas .a 402 to 998 1 to 602       602/947
(63 %)
8 diff
(99.2 %id)
BE889719 leiomyosarcoma, uterus .a 436 to 1203 1 to 775       775/845
(91 %)
20 diff
(97.7 %id)
BM041467 Kidney, Wilms' tumor, cell line .a 477 to 1188 728 to 3       726/781
(92 %)
0 diff
(100 %id)
BU633385 cell lines, Chondrosarcoma .a 491 to 1261 784 to 19   AAA   766/766
(100 %)
10 diff
(98.7 %id)
CN363272 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 497 to 1134 1 to 635       635/635
(100 %)
2 diff
(99.7 %id)
BM712297 eye, lens .a 505 to 823 1 to 319   fully sequenced,   319/319
(100 %)
0 diff
(100 %id)
CK820176 Islets of Langerhans, Pancreas .a 531 to 1132 1 to 599       599/599
(100 %)
2 diff
(99.7 %id)
BQ772536 Chondrosarcoma Cell line .a 571 to 1261 706 to 19   AAA   688/688
(100 %)
3 diff
(99.6 %id)
CA423477 cell lines, Chondrosarcoma .a 618 to 1261 658 to 19   AAA   640/644
(99 %)
3 diff
(99.6 %id)
BQ477323 insulinoma, Pancreas .a 633 to 1261 646 to 16   AAA   631/631
(100 %)
3 diff
(99.6 %id)
BE646553 B-cell, chronic lymphotic leukemia .a 637 to 1262 630 to 7       624/635
(98 %)
0 diff
(100 %id)
BQ006657 Chondrosarcoma, Left Pelvis .a 637 to 1261 640 to 19   AAA   622/622
(100 %)
5 diff
(99.2 %id)
AI074023 B-cell, chronic lymphotic leukemia .a 640 to 1262 631 to 9       623/631
(98 %)
0 diff
(100 %id)
AL581056 T cells from T cell leukemia .a 655 to 1242 583 to 1   fully sequenced,   583/583
(100 %)
7 diff
(98.8 %id)
AL581994 B cells from Burkitt lymphoma .a 665 to 1230 563 to 1   fully sequenced,   563/563
(100 %)
7 diff
(98.8 %id)
BM126020 Islets of Langerhans, Pancreas .a 685 to 1262 575 to 1       575/575
(100 %)
2 diff
(99.7 %id)
CK818882 Islets of Langerhans, Pancreas .a 703 to 1262 557 to 1       557/557
(100 %)
1 diff
(99.9 %id)
BI022914 marrow .a 753 to 1087 338 to 8       331/338
(97 %)
0 diff
(100 %id)
BU947898 insulinoma, Pancreas .a 776 to 1261 1 to 486       486/486
(100 %)
5 diff
(99.0 %id)
BM703357 eye, human retina .a 777 to 1214 1 to 435       435/437
(99 %)
3 diff
(99.4 %id)
BF798611 colon_ins .a 778 to 1023 12 to 256       245/267
(91 %)
3 diff
(98.9 %id)
BM670962 eye, lens .a 793 to 1261 484 to 19   fully sequenced, AAA   466/466
(100 %)
1 diff
(99.8 %id)
BM790455 Ascites, stomach .a 797 to 1261 1 to 462   AAA   462/462
(100 %)
1 diff
(99.8 %id)
BM768406 stomach .a 812 to 1260 1 to 449       449/449
(100 %)
0 diff
(100 %id)
BM855367 stomach .a 812 to 1008 1 to 199       199/199
(100 %)
3 diff
(98.5 %id)
BP430115   .a 815 to 1242 1 to 424       424/424
(100 %)
7 diff
(98.4 %id)
AI857713 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 851 to 1262 414 to 3       412/414
(99 %)
0 diff
(100 %id)
AW731620 cervix .a 853 to 1261 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
AI982842 adenocarcinoma, Pancreas .a 854 to 1261 417 to 12   AAA   406/406
(100 %)
8 diff
(98.1 %id)
BM739464 Ascites, stomach .a 868 to 1261 1 to 391   AAA   391/391
(100 %)
1 diff
(99.8 %id)
BQ771482 Chondrosarcoma Grade II, Left Pelvis .a 870 to 1261 407 to 19   AAA   389/389
(100 %)
2 diff
(99.5 %id)
AA252127 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 874 to 1015 1 to 138   fully sequenced,   138/138
(100 %)
2 diff
(98.6 %id)
TI_154055547   .a 878 to 1261 466 to 86   AAA   381/954
(39 %)
1 diff
(99.9 %id)
D82277   .a 880 to 1251 1 to 368       368/371
(99 %)
4 diff
(99.0 %id)
D82455   .a 880 to 1214 1 to 331       331/342
(96 %)
2 diff
(99.5 %id)
D82463   .a 880 to 1187 1 to 305       305/305
(100 %)
1 diff
(99.7 %id)
D82508   .a 880 to 1214 1 to 332       332/332
(100 %)
1 diff
(99.7 %id)
D82553   .a 880 to 1214 1 to 331       331/331
(100 %)
2 diff
(99.4 %id)
BF244375 brain, glioblastoma .a 890 to 1263 1 to 371   AAA   371/371
(100 %)
3 diff
(99.2 %id)
BF217721 brain, glioblastoma .a 890 to 1261 1 to 371       371/880
(42 %)
4 diff
(99.6 %id)
BM696010 eye, human retina .a 908 to 1261 1 to 351   AAA   351/351
(100 %)
1 diff
(99.8 %id)
AI282328 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 911 to 1261 348 to 1       348/348
(100 %)
1 diff
(99.8 %id)
BE077274 breast .a 948 to 1208 72 to 332       261/332
(78 %)
0 diff
(100 %id)
AA572925 Prostate, prostatic intraepithelial neoplasia - highgrade .a 948 to 1241 1 to 295       295/295
(100 %)
8 diff
(97.3 %id)
AI246907 adenocarcinoma, Pancreas .a 954 to 1261 321 to 14   AAA   308/308
(100 %)
0 diff
(100 %id)
AA810456 germinal center B cell .a 967 to 1261 305 to 11   AAA   295/295
(100 %)
2 diff
(99.4 %id)
AA252076 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 985 to 1261 275 to 1   fully sequenced,   275/275
(100 %)
3 diff
(99.0 %id)
AI264713 adenocarcinoma, Pancreas .a 993 to 1259 286 to 20       267/286
(93 %)
0 diff
(100 %id)
AW573588 Venae .a 1005 to 1260 1 to 256       256/265
(96 %)
3 diff
(98.9 %id)
BI037158 nervous_tumor .a 1005 to 1150 1 to 146       146/146
(100 %)
1 diff
(99.4 %id)
BI037159 nervous_tumor .a 1005 to 1150 1 to 147       147/147
(100 %)
4 diff
(97.3 %id)
AA927730 pooled germ cell tumors .a 1035 to 1262 229 to 2       228/229
(99 %)
0 diff
(100 %id)
D82469   .a 1058 to 1262 1 to 205       205/212
(96 %)
4 diff
(98.2 %id)
GD136885   .a 1095 to 1262 1 to 168       168/182
(92 %)
3 diff
(98.4 %id)
GD136886   .a 1095 to 1262 1 to 168       168/183
(91 %)
3 diff
(98.4 %id)
BG059772 brain, glioblastoma without EGFR amplification .a 1101 to 1261 163 to 1       163/163
(100 %)
6 diff
(96.4 %id)
BE618139 eye, retinoblastoma .b 1 to 626 1 to 628   tiling clone,   628/629
(99 %)
6 diff
(99.1 %id)
DA428429 colon .b 176 to 645 2 to 471   capped   470/476
(98 %)
4 diff
(99.2 %id)
GU354323   .b 176 to 1764 1 to 1589 exact tiling clone, AAA   1589/1589
(100 %)
0 diff
(100 %id)
DA375422 thalamus .c 1 to 493 8 to 501   tiling clone, capped   500/500
(100 %)
2 diff
(99.6 %id)
CN428540 embryonic stem cells, DMSO-treated H9 cellline .c 20 to 354 1 to 335       335/335
(100 %)
3 diff
(99.2 %id)
EB387824 eye, optic nerve .c 90 to 840 1 to 752   tiling clone,   752/752
(100 %)
1 diff
(99.9 %id)
AK097095 Spleen .c 118 to 2276 1 to 2161 exact available from FLJ,   2161/2161
(100 %)
5 diff
(99.8 %id)
DA932193 Spleen .c 119 to 537 2 to 422   capped   421/421
(100 %)
3 diff
(99.3 %id)
AI929143 brain, frontal lobe .c 262 to 701 1 to 442       442/442
(100 %)
8 diff
(98.2 %id)
BG700233 brain, hippocampus .c 459 to 1243 1 to 783       783/783
(100 %)
11 diff
(98.6 %id)
DA367617 subthalamic nucleus .c 460 to 1017 2 to 559   capped   558/558
(100 %)
4 diff
(99.3 %id)
TI_45379716   .c 472 to 1262 87 to 884       798/889
(89 %)
5 diff
(99.5 %id)
TI_57218702   .c 472 to 1362 31 to 923       893/923
(96 %)
11 diff
(98.9 %id)
BI488861 brain .c 477 to 1262 1 to 793       793/798
(99 %)
10 diff
(98.8 %id)
BI755544 brain .c 478 to 1362 1 to 888       888/888
(100 %)
12 diff
(98.7 %id)
BX461363 brain, fetal brain .c 481 to 1473 1 to 988       988/988
(100 %)
8 diff
(99.2 %id)
BX461242 brain, fetal brain .c 509 to 1459 1 to 939       939/979
(95 %)
14 diff
(98.6 %id)
BQ067983 brain .c 514 to 1334 20 to 843       824/1064
(77 %)
10 diff
(99.1 %id)
CR605840 adult brain .c 515 to 2243 1 to 1729 exact     1729/1729
(100 %)
0 diff
(100 %id)
AL532924 adult brain, brain .c 515 to 1464 1 to 949       925/997
(92 %)
29 diff
(97.1 %id)
CR597631 B cells (Ramos cell line) Cot 25-normalized .c 516 to 2246 1 to 1731 exact tiling clone,   1731/1731
(100 %)
0 diff
(100 %id)
BX342488   .c 516 to 1436 1 to 911   fully sequenced,   911/911
(100 %)
6 diff
(99.4 %id)
BQ432174 leiomyosarcoma, uterus .c 542 to 1402 1 to 867       867/867
(100 %)
21 diff
(97.6 %id)
CB265611 adipose .c 546 to 918 1 to 373       373/373
(100 %)
2 diff
(99.5 %id)
BG334453 melanotic melanoma, skin .c 568 to 1197 1 to 654       504/654
(77 %)
32 diff
(95.2 %id)
BE386862 melanotic melanoma, skin .c 570 to 1170 1 to 604       604/604
(100 %)
11 diff
(98.2 %id)
BF345406 anaplastic oligodendroglioma with 1p/19qloss, brain .c 573 to 1341 1 to 756       756/950
(79 %)
24 diff
(97.5 %id)
BF027663 melanotic melanoma, skin .c 584 to 1325 41 to 785       745/909
(81 %)
18 diff
(98.1 %id)
BE384745 melanotic melanoma, skin .c 588 to 1261 1 to 671       671/770
(87 %)
7 diff
(99.1 %id)
BE729769 melanotic melanoma, skin .c 588 to 1385 1 to 794       794/794
(100 %)
24 diff
(97.0 %id)
BE729632 melanotic melanoma, skin .c 588 to 1247 1 to 662       662/662
(100 %)
3 diff
(99.6 %id)
BE728092 melanotic melanoma, skin .c 588 to 1334 1 to 741       741/983
(75 %)
10 diff
(99.0 %id)
BF026386 melanotic melanoma, skin .c 588 to 1330 1 to 747       747/759
(98 %)
7 diff
(99.1 %id)
BM722635 eye, fetal eye .c 613 to 1221 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
BF308891 muscle, rhabdomyosarcoma .c 708 to 1477 1 to 746       746/769
(97 %)
37 diff
(95.2 %id)
BC000412 Muscle, rhabdomyosarcoma .c 709 to 2276 1 to 1569 exact available from MGC, AAA   1569/1569
(100 %)
3 diff
(99.9 %id)
BC008956 Muscle, rhabdomyosarcoma .c 709 to 2276 1 to 1569   available from MGC, AAA   1569/1569
(100 %)
3 diff
(99.9 %id)
AW410310 muscle, rhabdomyosarcoma .c 709 to 1205 26 to 522       497/522
(95 %)
0 diff
(100 %id)
CN428539 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 727 to 1480 1 to 753       753/753
(100 %)
9 diff
(98.9 %id)
BF219776 muscle, rhabdomyosarcoma .c 728 to 1415 1 to 684       686/687
(99 %)
14 diff
(98.0 %id)
BE294512 muscle, rhabdomyosarcoma .c 728 to 1256 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
CN428536 embryonic stem cells, cell lines H1, H7, andH9 .c 732 to 1380 11 to 659       649/659
(98 %)
0 diff
(100 %id)
BX418669 brain, fetal brain .c 732 to 1620 1 to 888       888/888
(100 %)
4 diff
(99.6 %id)
BX411489 adult brain, brain .c 779 to 1709 919 to 5       915/919
(99 %)
21 diff
(97.8 %id)
BF945984 nervous_normal .c 794 to 1204 1 to 415       415/415
(100 %)
11 diff
(97.4 %id)
CN428542 embryonic stem cells, DMSO-treated H9 cellline .c 833 to 1481 1 to 653       653/653
(100 %)
6 diff
(99.1 %id)
CB113323 Liver .c 834 to 1357 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
CN270102 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 887 to 1034 1 to 148       148/148
(100 %)
1 diff
(99.4 %id)
BQ879065 dorsal root ganglia .c 930 to 1836 1 to 914       914/914
(100 %)
13 diff
(98.6 %id)
BX342487   .c 1406 to 2246 842 to 1   fully sequenced,   842/842
(100 %)
7 diff
(99.2 %id)
TI_227713774   .c 1546 to 2276 800 to 68   AAA   733/968
(75 %)
54 diff
(94.5 %id)
BQ640263 eye, retina .c 1592 to 1921 1 to 329       329/405
(81 %)
8 diff
(98.1 %id)
BU620204 cell lines, Chondrosarcoma .c 1609 to 2276 684 to 19   AAA   666/666
(100 %)
4 diff
(99.4 %id)
CF135043 CNCAP(3)T-225 cell line, Prostate .c 1613 to 2021 1 to 409       409/409
(100 %)
6 diff
(98.6 %id)
TI_154163240   .c 1620 to 2276 81 to 739       659/701
(94 %)
19 diff
(97.3 %id)
BU944736 adenocarcinoma, cell line, breast .c 1633 to 2273 34 to 675   AAA   642/675
(95 %)
0 diff
(100 %id)
BM679274 eye, fetal eye .c 1644 to 2273 648 to 19   AAA   630/630
(100 %)
1 diff
(99.9 %id)
T47423 placenta .c 1648 to 1955 1 to 311       311/311
(100 %)
11 diff
(96.5 %id)
BX435382 brain, fetal brain .c 1683 to 2252 577 to 1       577/936
(61 %)
31 diff
(96.7 %id)
BM995503 lung, Metastatic Chondrosarcoma .c 1695 to 2276 598 to 16   AAA   583/583
(100 %)
1 diff
(99.9 %id)
CR989502 T-Lymphocytes .c 1745 to 2277 1 to 533       533/538
(99 %)
1 diff
(99.9 %id)
BF434836 Kidney .c 1783 to 2276 494 to 1       494/494
(100 %)
0 diff
(100 %id)
TI_153989068   .c 1787 to 2272 580 to 96   AAA   485/486
(99 %)
14 diff
(97.2 %id)
AI340085   .c 1809 to 2276 479 to 12   AAA   468/468
(100 %)
1 diff
(99.8 %id)
AL135093 melanoma (MeWo cell line) .c 1810 to 2054 1 to 245       245/245
(100 %)
3 diff
(98.8 %id)
AI928893 brain, frontal lobe .c 1847 to 2279 436 to 2       435/436
(99 %)
0 diff
(100 %id)
CN428537 embryonic stem cells, DMSO-treated H9 cellline .c 1858 to 2078 1 to 221       221/221
(100 %)
1 diff
(99.6 %id)
AA828276 germinal center B cell .c 1875 to 2279 412 to 7   tiling clone,   406/412
(98 %)
0 diff
(100 %id)
AI564943 anaplastic oligodendroglioma, brain .c 1876 to 2276 402 to 1       402/402
(100 %)
3 diff
(99.3 %id)
AI567362 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1879 to 2279 408 to 7       402/408
(98 %)
0 diff
(100 %id)
AI613211 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1890 to 2273 402 to 18   AAA   385/393
(97 %)
3 diff
(99.3 %id)
AW205226   .c 1897 to 2272 393 to 18   AAA   376/376
(100 %)
4 diff
(99.0 %id)
AW273273 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1900 to 2278 380 to 1       380/380
(100 %)
1 diff
(99.8 %id)
T47424 placenta .c 1960 to 2246 285 to 1       285/285
(100 %)
2 diff
(99.3 %id)
BU589662 mixed (pool of 40 RNAs) .c 1969 to 2280 1 to 313   AAA   313/313
(100 %)
5 diff
(98.5 %id)
AW410311 muscle, rhabdomyosarcoma .c 1976 to 2219 245 to 1       245/245
(100 %)
5 diff
(98.0 %id)
AI654777 pooled germ cell tumors .c 1985 to 2278 295 to 1       295/295
(100 %)
1 diff
(99.7 %id)
AW169221 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1992 to 2276 304 to 19   AAA   286/286
(100 %)
9 diff
(96.9 %id)
BF220164 muscle, rhabdomyosarcoma .c 2022 to 2203 191 to 1       581/792
(73 %)
33 diff
(95.9 %id)
AI632233 pooled germ cell tumors .c 2026 to 2277 253 to 1       253/253
(100 %)
5 diff
(98.1 %id)
N47012 multiple sclerosis lesions .c 2082 to 2272 193 to 2       192/193
(99 %)
0 diff
(100 %id)
AI932923 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 2115 to 2276 165 to 1       165/197
(83 %)
11 diff
(94.5 %id)
BF337707 brain, glioblastoma with EGFR amplification .c 2146 to 2279 1 to 134       134/145
(92 %)
2 diff
(98.7 %id)
DA964083 stomach .d 1 to 544 2 to 545   tiling clone, capped   544/544
(100 %)
0 diff
(100 %id)
BI907663 leukocyte .d 20 to 668 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
TI_57234031   .d 20 to 792 32 to 807       776/862
(90 %)
11 diff
(98.8 %id)
NM_013301.2   .d 20 to 2012 1 to 1993 exact RefSeq,   1993/1993
(100 %)
0 diff
(100 %id)
AW403323 lymph .d 82 to 397 8 to 323       316/323
(97 %)
0 diff
(100 %id)
TI_154139978   .d 82 to 567 78 to 569       492/625
(78 %)
16 diff
(97.5 %id)
TI_154143029   .d 82 to 710 82 to 715       634/744
(85 %)
29 diff
(96.2 %id)
TI_44346288   .d 204 to 1095 149 to 1035       887/1035
(85 %)
15 diff
(98.6 %id)
BI668321 brain, hypothalamus .d 207 to 1095 1 to 884       884/884
(100 %)
25 diff
(97.2 %id)
DB499180.
matches multiple genes
hypothalamus .d 212 to 684 1 to 473     also hits gene boyty 473/473
(100 %)
2 diff
(99.6 %id)
DB499211.
matches multiple genes
hypothalamus .d 212 to 696 1 to 485     also hits gene boyty 485/485
(100 %)
2 diff
(99.6 %id)
BQ671101 epidermoid carcinoma, cell line, salivary gland .d 442 to 1213 27 to 806       780/1005
(77 %)
35 diff
(96.6 %id)
BQ889174 epidermoid carcinoma, cell line, salivary gland .d 444 to 1180 1 to 745       745/908
(82 %)
19 diff
(98.0 %id)
BQ670558 epidermoid carcinoma, cell line, salivary gland .d 444 to 1066 1 to 631       631/982
(64 %)
23 diff
(97.7 %id)
CR593563 B cells (Ramos cell line) Cot 25-normalized .d 462 to 1973 1 to 1512 exact     1512/1512
(100 %)
0 diff
(100 %id)
CR604697 fetal brain .d 462 to 1944 1 to 1483 exact     1483/1483
(100 %)
0 diff
(100 %id)
CR608767 Neuroblastoma Cot 50-normalized .d 462 to 1979 1 to 1518 exact tiling clone,   1518/1518
(100 %)
0 diff
(100 %id)
CR622650 Neuroblastoma Cot 50-normalized .d 462 to 1976 1 to 1515 exact     1515/1515
(100 %)
0 diff
(100 %id)
AL528545 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 462 to 1285 1 to 820       820/983
(83 %)
15 diff
(98.5 %id)
AL530607 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 462 to 1480 1 to 1005       1005/1079
(93 %)
47 diff
(95.7 %id)
BX366102 Neuroblastoma Cot 50-normalized .d 462 to 1274 1 to 812       812/849
(95 %)
17 diff
(98.0 %id)
AL539815 brain, fetal brain .d 462 to 1189 1 to 725   fully sequenced,   725/725
(100 %)
7 diff
(99.1 %id)
BX401802   .d 462 to 1189 1 to 726   fully sequenced,   726/726
(100 %)
8 diff
(98.9 %id)
BQ224722 melanotic melanoma, skin .d 464 to 1197 1 to 742       742/907
(81 %)
25 diff
(97.3 %id)
BU542325 carcinoma, cell line, Prostate .d 465 to 1289 1 to 832       832/941
(88 %)
20 diff
(97.9 %id)
AF054984 brain .d 467 to 2009 1 to 1543 Q154* AAA   1543/1543
(100 %)
3 diff
(99.9 %id)
U79303 brain .d 467 to 2009 1 to 1543 Q154* AAA   1543/1543
(100 %)
3 diff
(99.9 %id)
BX385429   .d 471 to 1519 1 to 1027       951/1027
(92 %)
44 diff
(95.8 %id)
CR610458 B cells (Ramos cell line) Cot 25-normalized .d 472 to 1930 1 to 1459 exact     1459/1459
(100 %)
0 diff
(100 %id)
BX341205   .d 482 to 962 1 to 480       480/480
(100 %)
6 diff
(98.8 %id)
BI918388 brain .d 483 to 1242 31 to 814       746/1269
(58 %)
28 diff
(97.8 %id)
TI_57238189   .d 483 to 1242 31 to 814       746/1269
(58 %)
28 diff
(97.8 %id)
CN428538 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 489 to 875 1 to 385       385/385
(100 %)
4 diff
(99.0 %id)
TI_57180316   .d 499 to 1433 36 to 968       933/968
(96 %)
15 diff
(98.5 %id)
BI770317 pooled lung and spleen .d 500 to 1265 1 to 766       766/771
(99 %)
7 diff
(99.1 %id)
CR611450 HeLa cells Cot 25-normalized .d 584 to 1980 1 to 1397 exact     1397/1397
(100 %)
0 diff
(100 %id)
CR612899 HeLa cells Cot 25-normalized .d 584 to 1978 1 to 1395 exact     1395/1395
(100 %)
0 diff
(100 %id)
BX400860   .d 584 to 1416 1 to 828   fully sequenced,   828/828
(100 %)
5 diff
(99.4 %id)
BX384013   .d 584 to 1189 1 to 605   fully sequenced,   605/605
(100 %)
4 diff
(99.4 %id)
DA393698 thalamus .d 643 to 1213 2 to 573   capped   572/572
(100 %)
6 diff
(99.0 %id)
CB154643 brain .d 644 to 1220 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
BU857260 adenocarcinoma, cell line, breast .d 657 to 1455 1 to 803       803/951
(84 %)
12 diff
(98.8 %id)
DB467461.
matches multiple genes
hippocampus .d 658 to 890 1 to 230     also hits gene boyty 230/262
(87 %)
20 diff
(92.4 %id)
BP382667 adipose tissue .d 664 to 1261 1 to 598       598/598
(100 %)
7 diff
(98.9 %id)
GU354321   .d 665 to 2009 1 to 1345 exact tiling clone, AAA   1345/1345
(100 %)
0 diff
(100 %id)
BU521485 leiomyosarcoma, uterus .d 665 to 1269 1 to 615       615/1116
(55 %)
16 diff
(98.6 %id)
BG430154 Kidney .d 670 to 1391 1 to 720       720/720
(100 %)
6 diff
(99.2 %id)
BM805193 brain, hippocampus .d 674 to 1118 1 to 446       446/1405
(31 %)
15 diff
(99.0 %id)
BI668230 brain, hypothalamus .d 680 to 1544 6 to 866       861/870
(98 %)
17 diff
(98.1 %id)
TI_44346372   .d 680 to 1544 86 to 946       861/950
(90 %)
17 diff
(98.3 %id)
T08797   .d 688 to 904 1 to 216       216/216
(100 %)
3 diff
(98.7 %id)
BM544665 brain, hippocampus .d 693 to 1594 14 to 926       913/1105
(82 %)
25 diff
(97.8 %id)
CN428535 embryonic stem cells, cell lines H1, H7, andH9 .d 710 to 1224 1 to 515       515/515
(100 %)
3 diff
(99.5 %id)
BF845322 head_neck .d 712 to 1110 397 to 1     Submitted on the opposite strand 397/405
(98 %)
14 diff
(96.6 %id)
TI_57148465   .d 715 to 1408 59 to 753       695/753
(92 %)
2 diff
(99.8 %id)
BI759781 pooled colon, kidney, stomach .d 723 to 1408 1 to 687       687/687
(100 %)
3 diff
(99.6 %id)
CN428541 embryonic stem cells, cell lines H1, H7, andH9 .d 746 to 1272 1 to 528       528/528
(100 %)
3 diff
(99.5 %id)
TI_1948153693   .d 754 to 1188 127 to 561   fully sequenced,   435/561
(77 %)
0 diff
(100 %id)
TI_1948153835   .d 754 to 1600 125 to 976 R207P V208R D209G R210Q N211G ... fully sequenced,   852/976
(87 %)
48 diff
(95.1 %id)
TI_1948153977   .d 754 to 1581 126 to 958   fully sequenced,   833/958
(86 %)
33 diff
(96.6 %id)
CR450308   .d 755 to 1213 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
CV026665 mixed .d 755 to 1127 1 to 374       374/374
(100 %)
18 diff
(95.2 %id)
TI_1948153565   .d 756 to 1189 124 to 557   fully sequenced,   434/557
(77 %)
1 diff
(99.9 %id)
BQ673963 epidermoid carcinoma, cell line, salivary gland .d 813 to 1554 1 to 762       762/938
(81 %)
27 diff
(97.2 %id)
BG752740 eye, normal pigmented retinal epithelium .d 847 to 1661 1 to 815       815/816
(99 %)
11 diff
(98.7 %id)
BU540793 epithelioid carcinoma cell line, Pancreas .d 852 to 1713 1 to 877       877/918
(95 %)
26 diff
(97.2 %id)
AL563796 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 886 to 1976 1087 to 1       1087/1087
(100 %)
51 diff
(95.4 %id)
BI224296 cervical carcinoma cell line, cervix .d 936 to 1673 1 to 746       746/990
(75 %)
16 diff
(98.4 %id)
BI224228 cervical carcinoma cell line, cervix .d 937 to 1627 1 to 689       689/689
(100 %)
4 diff
(99.5 %id)
AA160703 Pancreas .d 1038 to 1628 1 to 587       587/589
(99 %)
14 diff
(97.7 %id)
BI260767 cervical carcinoma cell line, cervix .d 1059 to 1620 12 to 574       563/574
(98 %)
1 diff
(99.9 %id)
BQ672886 epidermoid carcinoma, cell line, salivary gland .d 1068 to 1861 1 to 803       803/850
(94 %)
25 diff
(97.1 %id)
BQ673095 epidermoid carcinoma, cell line, salivary gland .d 1068 to 1718 1 to 650       650/966
(67 %)
7 diff
(99.3 %id)
AL564927 adult brain, brain .d 1076 to 1976 902 to 1       902/905
(99 %)
21 diff
(97.7 %id)
BF981810 duodenal adenocarcinoma, cell line, small intestine .d 1087 to 1674 1 to 587       587/1133
(51 %)
8 diff
(99.3 %id)
BX393145   .d 1123 to 2003 893 to 5       889/893
(99 %)
16 diff
(98.3 %id)
BQ952018 epidermoid carcinoma, cell line, lung .d 1154 to 1824 1 to 677       677/1019
(66 %)
14 diff
(98.7 %id)
BQ675537 epidermoid carcinoma, cell line, salivary gland .d 1158 to 1729 1 to 576       576/963
(59 %)
20 diff
(98.0 %id)
TI_1948153694   .d 1158 to 1596 564 to 126   fully sequenced,   439/564
(77 %)
1 diff
(99.9 %id)
AL568062 brain, fetal brain .d 1159 to 1944 786 to 1   fully sequenced,   786/786
(100 %)
14 diff
(98.3 %id)
BX384012   .d 1159 to 1980 824 to 1   fully sequenced,   824/824
(100 %)
21 diff
(97.5 %id)
BX401801   .d 1159 to 1941 804 to 25   fully sequenced,   780/804
(97 %)
2 diff
(99.8 %id)
TI_1948153566   .d 1159 to 1596 564 to 127   fully sequenced,   438/564
(77 %)
1 diff
(99.9 %id)
TI_1948153836   .d 1159 to 1596 564 to 127   fully sequenced,   438/564
(77 %)
1 diff
(99.9 %id)
TI_1948153978   .d 1159 to 1596 563 to 126   fully sequenced,   438/563
(77 %)
1 diff
(99.9 %id)
BU150563 epidermoid carcinoma, cell line, salivary gland .d 1178 to 1929 1 to 760       760/937
(81 %)
23 diff
(97.6 %id)
BQ670601 epidermoid carcinoma, cell line, salivary gland .d 1178 to 1785 1 to 616       616/1140
(54 %)
19 diff
(98.4 %id)
BF844909 head_neck .d 1234 to 1579 348 to 1     Submitted on the opposite strand 348/352
(98 %)
6 diff
(98.3 %id)
BF844910 head_neck .d 1234 to 1519 290 to 5     Submitted on the opposite strand 286/294
(97 %)
3 diff
(99.0 %id)
BF844911 head_neck .d 1234 to 1506 272 to 1     Submitted on the opposite strand 272/276
(98 %)
4 diff
(98.6 %id)
AL528544 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 1279 to 1947 711 to 36       676/1023
(66 %)
46 diff
(95.6 %id)
BX384011   .d 1386 to 1978 594 to 1   fully sequenced,   594/594
(100 %)
15 diff
(97.5 %id)
AA159472 Pancreas .d 1640 to 2008 370 to 3       368/370
(99 %)
0 diff
(100 %id)
DA003884   .e 1 to 583 2 to 584   tiling clone, capped   583/583
(100 %)
1 diff
(99.9 %id)
BP195976 brain .e 85 to 666 1 to 582       582/583
(99 %)
1 diff
(99.9 %id)
BG705095 brain, hippocampus .e 187 to 857 6 to 677       672/677
(99 %)
5 diff
(99.3 %id)
GU354322   .e 208 to 1608 1 to 1401 exact tiling clone, AAA   1401/1401
(100 %)
0 diff
(100 %id)
BX361989   .e 211 to 1116 8 to 909       902/909
(99 %)
12 diff
(98.7 %id)
R73489 breast .e 233 to 365 1 to 132       132/132
(100 %)
3 diff
(97.8 %id)
R76309 breast .e 233 to 648 1 to 422       422/455
(92 %)
18 diff
(96.1 %id)
BU902332 leiomyosarcoma, uterus .f 1 to 1147 1 to 1148 exact tiling clone,   1148/1157
(99 %)
68 diff
(94.2 %id)
BG502529 embryonal carcinoma, testis .g 1 to 706 1 to 706 A94P S95V A97L P98Q G99A ... tiling clone,   706/710
(99 %)
9 diff
(98.8 %id)
BG988577 head_neck .h-u 1 to 337 352 to 17   tiling clone,   336/352
(95 %)
0 diff
(100 %id)
AK123294 amygdala .h-u 130 to 2269 1 to 2140 E104G tiling clone, available from FLJ, AAA   2140/2140
(100 %)
2 diff
(100.0 %id)
DA177479 amygdala .h-u 131 to 667 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
BE464175 Kidney .h-u 516 to 971 456 to 1   tiling clone,   456/456
(100 %)
3 diff
(99.4 %id)
DB302806 amygdala .h-u 1900 to 2269 370 to 1       370/372
(99 %)
0 diff
(100 %id)
AF184939   .h-u 1952 to 3659 1 to 1705   tiling clone, AAA   1705/1705
(100 %)
3 diff
(99.9 %id)
NM_016202.2   .h-u 2242 to 3659 1 to 1418   RefSeq, AAA   1418/1418
(100 %)
0 diff
(100 %id)
BM700178 eye, lens .h-u 2242 to 2789 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
BM702249 eye, optic nerve .h-u 2247 to 2917 1 to 671       671/672
(99 %)
4 diff
(99.5 %id)
DR006746 Spleen .h-u 2270 to 2979 20 to 728       709/728
(97 %)
0 diff
(100 %id)
BY994929   .h-u 2396 to 3084 10 to 698       689/698
(98 %)
0 diff
(100 %id)
BC017698 Prostate, adenocarcinoma. .h-u 2442 to 3659 1 to 1215   available from MGC, AAA   1215/1215
(100 %)
4 diff
(99.7 %id)
BG179407 adenocarcinoma, cell line, Prostate .h-u 2442 to 2767 1 to 324       324/999
(32 %)
5 diff
(99.5 %id)
BM710177 eye, optic nerve .h-u 2491 to 3002 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BU957315 adenocarcinoma, cell line, breast .h-u 2548 to 3275 1 to 737   tiling clone,   737/968
(76 %)
14 diff
(98.6 %id)
AI697969 carcinoid, lung .h-u 2561 to 2914 1 to 354     Submitted on the opposite strand 354/355
(99 %)
4 diff
(98.9 %id)
BE218098 carcinoid, lung .h-u 2561 to 2913 1 to 353     Submitted on the opposite strand 353/355
(99 %)
5 diff
(98.6 %id)
BM670183 eye, lens .h-u 3019 to 3659 656 to 19   AAA   638/638
(100 %)
6 diff
(99.1 %id)
BM664928 eye, optic nerve .h-u 3164 to 3659 511 to 19   AAA   493/493
(100 %)
3 diff
(99.4 %id)
BM671600 eye, optic nerve .h-u 3179 to 3659 499 to 19   tiling clone, AAA   481/481
(100 %)
3 diff
(99.4 %id)
BM688339 eye, human retina .i 1 to 597 3 to 599 L2G V171G K184X tiling clone,   597/599
(99 %)
2 diff
(99.7 %id)
CR608870 fetal liver .j 1 to 1623 1 to 1623 exact tiling clone,   1623/1623
(100 %)
0 diff
(100 %id)
BX443966 fetal liver, Liver .j 1 to 860 1 to 839   fully sequenced,   839/839
(100 %)
10 diff
(98.9 %id)
BM932005 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 1 to 481 482 to 1     Submitted on the opposite strand 482/482
(100 %)
1 diff
(99.8 %id)
DA923910 small intestine .j 8 to 410 2 to 404   capped   403/403
(100 %)
0 diff
(100 %id)
DA198199 brain .j 10 to 534 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
BF058512 fibrotheoma, ovary .j 21 to 498 1 to 478     Submitted on the opposite strand 478/478
(100 %)
0 diff
(100 %id)
AI864430 anaplastic oligodendroglioma, brain .j 37 to 366 1 to 330     Submitted on the opposite strand 330/330
(100 %)
0 diff
(100 %id)
DA319917 hippocampus .j 47 to 542 2 to 498   capped   497/497
(100 %)
1 diff
(99.8 %id)
BF368785 placenta_normal .j 70 to 355 14 to 299       286/299
(95 %)
0 diff
(100 %id)
BF829670 head_normal .j 122 to 740 1 to 615       615/615
(100 %)
20 diff
(96.8 %id)
BI000569 head_normal .j 126 to 445 5 to 319       315/321
(98 %)
12 diff
(96.3 %id)
BI000486 head_normal .j 128 to 429 7 to 308       302/308
(98 %)
3 diff
(99.1 %id)
BX443965 fetal liver, Liver .j 830 to 1623 779 to 1   fully sequenced,   779/779
(100 %)
12 diff
(98.5 %id)
BM546015 ovary (pool of 3) .k 1 to 687 1 to 688 P47S R116W S134V S138F L139P ... tiling clone,   688/1143
(60 %)
26 diff
(97.8 %id)
BC071620 Kidney, hypernephroma .l 1 to 1324 1 to 1324 exact tiling clone, available from MGC, AAA   1324/1324
(100 %)
1 diff
(100.0 %id)
BG163590 hypernephroma, cell line, Kidney .l 2 to 842 1 to 843 P105Q V106W L108S Q109R A110P ...     843/1005
(83 %)
44 diff
(95.7 %id)
AU310372 neuroblastoma .m 1 to 558 20 to 577   tiling clone,   558/577
(96 %)
1 diff
(99.9 %id)
AU310373 neuroblastoma .m 1026 to 1544 550 to 31   tiling clone, AAA   520/520
(100 %)
4 diff
(99.3 %id)
CR609477 B cells (Ramos cell line) Cot 25-normalized .n 1 to 1268 1 to 1268 exact tiling clone,   1268/1268
(100 %)
0 diff
(100 %id)
AL561410 B cells from Burkitt lymphoma .n 1 to 639 1 to 634 P27T L49I P85T A97D P108X ... fully sequenced,   634/634
(100 %)
9 diff
(98.6 %id)
BI669231 brain, hypothalamus .n 35 to 775 1 to 739 Q39K Q83X     739/739
(100 %)
9 diff
(98.8 %id)
TI_44346113   .n 37 to 775 83 to 819 Q39K Q83X     737/819
(89 %)
3 diff
(99.7 %id)
BI758773 brain .n 62 to 829 23 to 792 exact     770/792
(97 %)
7 diff
(99.2 %id)
TI_57216267   .n 62 to 829 23 to 792 exact     770/792
(97 %)
7 diff
(99.2 %id)
CN362725 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 63 to 776 1 to 715 exact     715/715
(100 %)
3 diff
(99.6 %id)
AF151023 umbilical cord blood .n 74 to 1300 1 to 1227 exact tiling clone, AAA   1227/1227
(100 %)
2 diff
(99.9 %id)
H08047 whole brain .n 74 to 504 1 to 432       432/441
(97 %)
7 diff
(98.5 %id)
NM_016535.3   .n 74 to 1298 1 to 1225 exact RefSeq, AAA   1225/1225
(100 %)
0 diff
(100 %id)
R60646 whole brain .n 75 to 476 1 to 404       404/404
(100 %)
12 diff
(97.1 %id)
R54543 whole brain .n 75 to 530 1 to 453       453/453
(100 %)
10 diff
(97.8 %id)
BM554927 amelanotic melanoma, cell line, skin .n 77 to 951 23 to 901 exact     879/1072
(81 %)
33 diff
(97.0 %id)
BM009081 amelanotic melanoma, cell line, skin .n 80 to 1005 1 to 925 exact     925/1029
(89 %)
34 diff
(96.7 %id)
BI092388 cervix .n 81 to 792 1 to 711 T117L R118G R119G     711/715
(99 %)
7 diff
(99.1 %id)
TI_59383795   .n 81 to 1005 61 to 984 exact     924/1028
(89 %)
33 diff
(96.8 %id)
BM009972 amelanotic melanoma, cell line, skin .n 85 to 762 1 to 678 exact     678/678
(100 %)
1 diff
(99.9 %id)
BM041055 Kidney, Wilms' tumor, cell line .n 85 to 554 1 to 472   fully sequenced,   472/472
(100 %)
1 diff
(99.8 %id)
TI_59384760   .n 86 to 762 53 to 729 exact     677/677
(100 %)
0 diff
(100 %id)
CB113771 Liver .n 86 to 674 1 to 589 exact     589/589
(100 %)
0 diff
(100 %id)
BM811442 amelanotic melanoma, cell line, skin .n 88 to 914 1 to 835 exact     835/1065
(78 %)
24 diff
(97.8 %id)
CB141863 Liver .n 92 to 471 1 to 380       380/380
(100 %)
5 diff
(98.7 %id)
TI_57202103   .n 93 to 904 27 to 835 exact     809/837
(96 %)
6 diff
(99.3 %id)
BE889060 leiomyosarcoma, uterus .n 95 to 840 1 to 738 P85Q V86W L88S Q89R A90P ...     738/738
(100 %)
16 diff
(97.9 %id)
BM925190 pooled lung and spleen .n 95 to 1114 3 to 1021 exact     1019/1025
(99 %)
15 diff
(98.6 %id)
BG168914 hypernephroma, cell line, Kidney .n 98 to 905 1 to 791 exact     791/1076
(73 %)
29 diff
(97.4 %id)
BI822906 pooled brain, lung, testis .n 101 to 904 1 to 801 exact     801/803
(99 %)
7 diff
(99.2 %id)
CB129947 Liver .n 101 to 673 1 to 573 exact     573/575
(99 %)
1 diff
(99.9 %id)
BC010097 Placenta, choriocarcinoma .n 102 to 1298 1 to 1197 exact available from MGC, AAA   1197/1197
(100 %)
0 diff
(100 %id)
BG281176 melanotic melanoma, skin .n 102 to 850 1 to 760 L3P S4Q Q5S P6S S7P ...     760/760
(100 %)
23 diff
(97.0 %id)
BG824327 adenocarcinoma cell line, colon .n 102 to 1016 1 to 922 exact     922/923
(99 %)
33 diff
(96.5 %id)
AK315603 skeletal muscle .n 103 to 841 1 to 739 exact     739/739
(100 %)
0 diff
(100 %id)
BP263955 small intestine .n 104 to 677 1 to 574 S18R     574/574
(100 %)
3 diff
(99.5 %id)
DA894676 skeletal muscle .n 104 to 656 2 to 554 exact capped   553/553
(100 %)
0 diff
(100 %id)
BC001219 Muscle, rhabdomyosarcoma .n 105 to 1298 1 to 1194 exact available from MGC, AAA   1194/1194
(100 %)
1 diff
(100.0 %id)
CB129949 Liver .n 105 to 299 1 to 195       195/195
(100 %)
0 diff
(100 %id)
DA604761   .n 106 to 599 2 to 495 exact capped   494/494
(100 %)
0 diff
(100 %id)
CN362720 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 110 to 769 1 to 660 exact     660/660
(100 %)
4 diff
(99.4 %id)
CR601401 B cells (Ramos cell line) Cot 25-normalized .n 112 to 1266 1 to 1155 exact     1155/1155
(100 %)
0 diff
(100 %id)
CR619004 T cells (Jurkat cell line) Cot10-normalized .n 112 to 1284 1 to 1173 exact     1173/1173
(100 %)
0 diff
(100 %id)
BX341185   .n 112 to 534 1 to 413   fully sequenced,   413/413
(100 %)
3 diff
(99.3 %id)
AL561579 B cells from Burkitt lymphoma .n 112 to 734 1 to 616 T65X Q72X fully sequenced,   616/616
(100 %)
5 diff
(99.2 %id)
CD653037 Embryonic Stem cells .n 112 to 860 10 to 753 exact     744/802
(92 %)
6 diff
(99.3 %id)
TI_57237288   .n 112 to 1056 29 to 971 exact     943/993
(94 %)
25 diff
(97.5 %id)
CD674137 eye, lens .n 116 to 674 1 to 559 exact     559/559
(100 %)
0 diff
(100 %id)
BG686575 B-cells, primary B-cells from tonsils (cell line) .n 119 to 663 1 to 551 V68L R77T R80S G84A K92Q ...     551/857
(64 %)
25 diff
(97.1 %id)
BI909057 leukocyte .n 119 to 1056 1 to 936 exact     936/958
(97 %)
25 diff
(97.4 %id)
BM018280 astrocytoma grade IV, cell line, brain .n 119 to 858 1 to 739 exact     739/739
(100 %)
3 diff
(99.6 %id)
BC071845 Primary B-Cells from Tonsils .n 120 to 1298 1 to 1179 exact available from MGC, AAA   1179/1179
(100 %)
0 diff
(100 %id)
TI_59388867   .n 120 to 858 102 to 839 exact     738/738
(100 %)
2 diff
(99.8 %id)
BU527605 epidermoid carcinoma, cell line, lung .n 121 to 1069 1 to 956 exact     956/956
(100 %)
16 diff
(98.4 %id)
BE385014 melanotic melanoma, skin .n 122 to 614 1 to 492 C107F     492/492
(100 %)
3 diff
(99.4 %id)
CN362723 embryonic stem cells, DMSO-treated H9 cellline .n 123 to 424 1 to 304       304/304
(100 %)
8 diff
(97.4 %id)
BE299874 muscle, rhabdomyosarcoma .n 123 to 658 1 to 531 P85Q V86W L88S Q89R A90P ... fully sequenced,   531/531
(100 %)
2 diff
(99.7 %id)
BE294024 muscle, rhabdomyosarcoma .n 124 to 801 1 to 673 P85Q V86W L88S Q89R A90P ...     673/674
(99 %)
7 diff
(99.0 %id)
BE790160 large cell carcinoma, lung .n 126 to 898 1 to 753 P85Q V86W L88S Q89R A90P ...     753/796
(94 %)
18 diff
(97.8 %id)
AA280100 germinal center B cell .n 128 to 658 1 to 529 G2A L3S S4A Q5A P6L ...     529/529
(100 %)
6 diff
(98.9 %id)
CB266366 adipose .n 131 to 723 1 to 597 C73V W74L W75V T76D R77E ...     597/597
(100 %)
17 diff
(97.2 %id)
BE259854 brain, neuroblastoma .n 135 to 803 1 to 709 G8R C9M W10L C11V C12L ...     548/763
(71 %)
49 diff
(93.6 %id)
CB267070 adipose .n 136 to 674 1 to 539 S4X R67X     539/542
(99 %)
1 diff
(99.9 %id)
CN362722 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 140 to 783 1 to 645 exact     645/645
(100 %)
2 diff
(99.7 %id)
CN362724 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 143 to 754 1 to 614 exact     614/614
(100 %)
2 diff
(99.7 %id)
CN362719 embryonic stem cells, DMSO-treated H9 cellline .n 147 to 710 1 to 565 exact     565/565
(100 %)
1 diff
(99.9 %id)
AJ713243 bone marrow .n 150 to 586 1 to 437 exact     437/437
(100 %)
0 diff
(100 %id)
N26434.
matches multiple genes
melanocyte .n 159 to 649 1 to 489 G2P L3Q S4Q Q5P P6S ...   also hits gene FOXO1 489/490
(99 %)
17 diff
(96.6 %id)
AA283994 germinal center B cell .n 162 to 436 1 to 274       274/274
(100 %)
3 diff
(99.0 %id)
CX785085 human embryonic stem cells .n 173 to 861 1 to 689 exact     689/689
(100 %)
1 diff
(99.9 %id)
BE279684 choriocarcinoma, placenta .n 176 to 762 63 to 688 A16C L17P S18Q L19P W20S ...     626/688
(90 %)
59 diff
(91.5 %id)
TI_1948089952   .n 241 to 569 129 to 460   fully sequenced,   332/460
(72 %)
12 diff
(97.4 %id)
CV025836 mixed .n 248 to 681 1 to 434       434/442
(98 %)
1 diff
(99.8 %id)
CV028380 mixed .n 248 to 698 1 to 451       451/451
(100 %)
1 diff
(99.8 %id)
TI_1948089956   .n 248 to 723 136 to 612       477/1054
(45 %)
13 diff
(98.8 %id)
BM695253 eye, optic nerve .n 287 to 637 1 to 351       351/351
(100 %)
1 diff
(99.8 %id)
CN362721 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 298 to 969 1 to 672       672/672
(100 %)
6 diff
(99.2 %id)
DN991643 brain, whole brain .n 351 to 900 33 to 582       550/582
(94 %)
0 diff
(100 %id)
AA064686 Pancreas .n 356 to 772 1 to 425       425/429
(99 %)
16 diff
(96.3 %id)
TI_154193161   .n 376 to 1136 50 to 806       757/1008
(75 %)
10 diff
(99.1 %id)
CF127611 Chondrosarcoma Lung Metastasis cell lines, lung .n 377 to 1102 1 to 726       726/726
(100 %)
0 diff
(100 %id)
BE390865 endometrium, adenocarcinoma cell line, uterus .n 383 to 1051 1 to 659       659/674
(97 %)
16 diff
(97.7 %id)
AW799052 uterus .n 387 to 629 256 to 17       240/259
(92 %)
0 diff
(100 %id)
W91972 heart .n 393 to 718 1 to 327       327/327
(100 %)
6 diff
(98.2 %id)
BQ673971 epidermoid carcinoma, cell line, salivary gland .n 424 to 1298 1 to 883   AAA   883/883
(100 %)
22 diff
(97.6 %id)
TI_57200092   .n 465 to 1299 31 to 860       830/867
(95 %)
14 diff
(98.4 %id)
AA307127 colon .n 466 to 920 1 to 453       453/453
(100 %)
3 diff
(99.4 %id)
BI818804 pooled brain, lung, testis .n 471 to 1299 1 to 825       825/832
(99 %)
13 diff
(98.5 %id)
AW250591 lung, small cell carcinoma .n 472 to 1013 10 to 551       542/551
(98 %)
0 diff
(100 %id)
BI224080 cervical carcinoma cell line, cervix .n 476 to 670 1 to 199       199/199
(100 %)
4 diff
(98.0 %id)
BM712801 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .n 488 to 782 1 to 295   fully sequenced,   295/295
(100 %)
0 diff
(100 %id)
BE263775 lung, small cell carcinoma .n 491 to 1177 1 to 683       683/728
(93 %)
11 diff
(98.5 %id)
BX374002   .n 504 to 1284 782 to 1   fully sequenced,   782/782
(100 %)
12 diff
(98.5 %id)
BQ650474 hepatocellular carcinoma, cell line, Liver .n 514 to 1034 1 to 522       522/1041
(50 %)
10 diff
(99.1 %id)
BM041721 Kidney, Wilms' tumor, cell line .n 524 to 1249 732 to 1   fully sequenced,   732/732
(100 %)
8 diff
(99.0 %id)
TI_1948089953   .n 539 to 846 440 to 125   fully sequenced,   316/440
(71 %)
11 diff
(97.5 %id)
BG170508 hypernephroma, cell line, Kidney .n 557 to 1303 1 to 755       755/1067
(70 %)
23 diff
(97.9 %id)
CA415470 Chondrosarcoma Grade II, Left Pelvis .n 559 to 1298 757 to 19   AAA   739/739
(100 %)
1 diff
(99.9 %id)
BG759211 B-cells, primary B-cells from tonsils (cell line) .n 565 to 1304 1 to 739       739/906
(81 %)
11 diff
(98.8 %id)
CN362718 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 604 to 1146 1 to 543       543/543
(100 %)
0 diff
(100 %id)
AL582624 B cells from Burkitt lymphoma .n 609 to 1237 653 to 34   fully sequenced,   620/653
(94 %)
25 diff
(96.2 %id)
BU625719 cell lines, Enchondroma .n 617 to 1298 699 to 19   AAA   681/681
(100 %)
2 diff
(99.8 %id)
BE300192 muscle, rhabdomyosarcoma .n 628 to 1264 654 to 19   fully sequenced,   636/654
(97 %)
8 diff
(98.8 %id)
AA148046   .n 665 to 947 1 to 289   fully sequenced,   289/289
(100 %)
1 diff
(99.7 %id)
BQ774311 Chondrosarcoma Grade II, Left Pelvis .n 665 to 1298 649 to 19   AAA   631/642
(98 %)
5 diff
(99.3 %id)
TI_149278110   .n 671 to 1298 765 to 138   AAA   628/628
(100 %)
0 diff
(100 %id)
AA303581 aorta .n 702 to 1015 1 to 313       313/313
(100 %)
3 diff
(99.1 %id)
AW952014   .n 704 to 1175 1 to 473       473/476
(99 %)
14 diff
(97.1 %id)
AL582750 B cells from Burkitt lymphoma .n 704 to 1258 557 to 9   fully sequenced,   549/557
(98 %)
3 diff
(99.5 %id)
AI563939 anaplastic oligodendroglioma, brain .n 704 to 1298 594 to 1       594/594
(100 %)
1 diff
(99.9 %id)
BU632370 cell lines, Chondrosarcoma .n 704 to 1298 613 to 19   AAA   595/595
(100 %)
0 diff
(100 %id)
CR985331 T-Lymphocytes .n 716 to 1297 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM998114 lung, Metastatic Chondrosarcoma .n 727 to 1298 590 to 19   AAA   572/572
(100 %)
0 diff
(100 %id)
BG112501 Bone, osteosarcoma, cell line .n 739 to 1299 1 to 560       560/585
(95 %)
5 diff
(99.2 %id)
DB320045   .n 741 to 1298 558 to 1       558/558
(100 %)
0 diff
(100 %id)
BM676142 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .n 752 to 1298 565 to 19   fully sequenced, AAA   547/547
(100 %)
1 diff
(99.9 %id)
BF217537 brain, glioblastoma .n 753 to 1296 1 to 544       544/788
(69 %)
18 diff
(97.8 %id)
BM715523 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .n 781 to 1299 1 to 519       519/522
(99 %)
1 diff
(99.9 %id)
W94919 heart .n 815 to 1298 502 to 12   AAA   491/492
(99 %)
11 diff
(97.8 %id)
AA886389 Kidney .n 831 to 1299 473 to 6       468/473
(98 %)
0 diff
(100 %id)
AI167949 pooled .n 831 to 1299 475 to 7       469/475
(98 %)
0 diff
(100 %id)
AI160019 uterus .n 831 to 1298 481 to 14   AAA   468/468
(100 %)
4 diff
(99.2 %id)
AI523219 aorta .n 845 to 1298 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
AI679948 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 846 to 1298 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AA480164 colon .n 858 to 1299 441 to 1       441/441
(100 %)
3 diff
(99.4 %id)
R60593 whole brain .n 859 to 1298 460 to 16   AAA   445/452
(98 %)
16 diff
(96.5 %id)
AI679440 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 862 to 1298 437 to 1       437/437
(100 %)
0 diff
(100 %id)
H99329.
matches multiple genes
melanocyte .n 876 to 1298 447 to 20   AAA also hits gene IQCB1 428/429
(99 %)
16 diff
(96.3 %id)
AA064644 Pancreas .n 882 to 1298 419 to 1       419/419
(100 %)
3 diff
(99.3 %id)
AA147993   .n 917 to 1298 378 to 1   fully sequenced,   378/378
(100 %)
2 diff
(99.5 %id)
BM701120 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .n 925 to 1120 1 to 196       196/196
(100 %)
0 diff
(100 %id)
H07940 whole brain .n 932 to 1298 394 to 15   AAA   380/391
(97 %)
16 diff
(96.0 %id)
AI520745 adenocarcinoma, Pancreas .n 933 to 1298 387 to 22   AAA   366/366
(100 %)
4 diff
(99.0 %id)
AA283759 germinal center B cell .n 976 to 1298 334 to 12   AAA   323/323
(100 %)
1 diff
(99.7 %id)
R54445 whole brain .n 980 to 1299 338 to 15       324/344
(94 %)
0 diff
(100 %id)
AI085856 breast .n 991 to 1299 315 to 9       307/315
(97 %)
0 diff
(100 %id)
BX109714 liver and spleen .n 998 to 1299 1 to 302       302/303
(99 %)
2 diff
(99.4 %id)
R11288 liver and spleen .n 999 to 1295 1 to 299   fully sequenced,   299/299
(100 %)
6 diff
(98.0 %id)
AA280033 germinal center B cell .n 999 to 1299 303 to 3       301/307
(98 %)
0 diff
(100 %id)
H69540 liver and spleen .n 1025 to 1299 276 to 2       275/276
(99 %)
0 diff
(100 %id)
AV743721 cord Blood .n 1059 to 1292 41 to 273   AAA   233/275
(84 %)
0 diff
(100 %id)
AI250356 lymph node, lymphoma, follicular mixed small and largecell .n 1060 to 1298 262 to 24   AAA   239/239
(100 %)
4 diff
(98.4 %id)
N70908 liver and spleen .n 1091 to 1299 213 to 5       209/213
(98 %)
0 diff
(100 %id)
BG271409 normal head/neck tissue .n 1096 to 1299 209 to 6       204/234
(87 %)
0 diff
(100 %id)
GD141325   .n 1097 to 1298 1 to 202   AAA   202/202
(100 %)
5 diff
(97.6 %id)
GD141332   .n 1097 to 1298 1 to 202   AAA   202/202
(100 %)
5 diff
(97.6 %id)
GD160039   .n 1097 to 1298 1 to 202   AAA   202/202
(100 %)
6 diff
(97.1 %id)
AI540673 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .n 1104 to 1299 196 to 1       196/196
(100 %)
0 diff
(100 %id)
R11229 liver and spleen .n 1129 to 1298 172 to 1   fully sequenced,   172/172
(100 %)
1 diff
(99.5 %id)
AA909579 pooled .n 1139 to 1298 173 to 15   AAA   159/159
(100 %)
2 diff
(98.8 %id)
AA775556 heart .n 1164 to 1299 135 to 1       135/135
(100 %)
1 diff
(99.3 %id)
AA809976 germinal center B cell .n 1182 to 1298 141 to 25   AAA   117/117
(100 %)
0 diff
(100 %id)
BM450957 eye, retinoblastoma .o 1 to 637 1 to 637   tiling clone,   637/927
(68 %)
11 diff
(98.9 %id)
BF124964 melanotic melanoma, skin .o 65 to 637 1 to 604       602/1102
(54 %)
33 diff
(97.1 %id)
BM738274 Ascites, stomach .o 175 to 683 1 to 507       507/507
(100 %)
18 diff
(96.5 %id)
Z99379 amygdala, ovary .o 397 to 847 1 to 451 D14N tiling clone,   451/451
(100 %)
7 diff
(98.5 %id)
AY927563   .p-u 1 to 752 1 to 752 exact tiling clone,   752/753
(99 %)
4 diff
(99.5 %id)
DA642823 Liver .q-u 1 to 552 10 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
AK055093 brain .q-u 1 to 2231 2 to 2232 E3G M47V T48A V61A tiling clone, available from FLJ,   2232/2734
(81 %)
11 diff
(99.6 %id)
DA198178 brain .q-u 1 to 510 2 to 512   capped   511/511
(100 %)
1 diff
(99.9 %id)
TI_151763026   .q-u 2 to 493 49 to 540     Submitted on the opposite strand 492/1024
(48 %)
1 diff
(100.0 %id)
TI_151763049   .q-u 2 to 493 47 to 538     Submitted on the opposite strand 492/1050
(46 %)
1 diff
(100.0 %id)
BM931984 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q-u 13 to 493 481 to 1     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
CV348418 placenta_normal .q-u 558 to 1022 1 to 465   tiling clone,   465/465
(100 %)
33 diff
(93.0 %id)
BF945402 nervous_normal .q-u 946 to 1237 306 to 15     Submitted on the opposite strand 292/323
(90 %)
0 diff
(100 %id)
BI006202 kidney_tumor .q-u 1020 to 1441 22 to 454   tiling clone,   433/477
(90 %)
6 diff
(98.8 %id)
BF741025 bocio_tumor .q-u 1550 to 1928 1 to 377       377/377
(100 %)
7 diff
(98.2 %id)
BF741826 bocio_tumor .q-u 1550 to 1995 1 to 446       446/446
(100 %)
7 diff
(98.5 %id)
BF741827 bocio_tumor .q-u 1551 to 1997 1 to 447       447/447
(100 %)
6 diff
(98.7 %id)
BF740687 bocio_tumor .q-u 1552 to 1928 16 to 388       373/388
(96 %)
0 diff
(100 %id)
BF741383 bocio_tumor .q-u 1552 to 1936 1 to 384       384/393
(97 %)
7 diff
(98.3 %id)
BF741772 bocio_tumor .q-u 1555 to 2000 5 to 452       448/467
(95 %)
6 diff
(98.8 %id)
BF741820 bocio_tumor .q-u 1555 to 1813 5 to 264       260/264
(98 %)
0 diff
(100 %id)
BF740592 bocio_tumor .q-u 1557 to 1844 1 to 286       286/286
(100 %)
10 diff
(96.6 %id)
BF740646 bocio_tumor .q-u 1557 to 1994 1 to 436   tiling clone,   436/436
(100 %)
10 diff
(97.8 %id)
BF741046 bocio_tumor .q-u 1566 to 2005 1 to 439       439/440
(99 %)
6 diff
(98.7 %id)
BF740578 bocio_tumor .q-u 1567 to 1967 403 to 1     Submitted on the opposite strand 403/403
(100 %)
14 diff
(96.6 %id)
BF740868 bocio_tumor .q-u 1567 to 1708 1 to 147       147/147
(100 %)
5 diff
(96.6 %id)
BF740875 bocio_tumor .q-u 1567 to 1997 1 to 431       431/431
(100 %)
1 diff
(99.8 %id)
BF741041 bocio_tumor .q-u 1567 to 1998 432 to 1     Submitted on the opposite strand 432/432
(100 %)
2 diff
(99.6 %id)
BF741310 bocio_tumor .q-u 1567 to 1923 359 to 1     Submitted on the opposite strand 359/359
(100 %)
15 diff
(95.9 %id)
BF741410 bocio_tumor .q-u 1567 to 1993 431 to 1     Submitted on the opposite strand 431/431
(100 %)
20 diff
(95.4 %id)
BF741757 bocio_tumor .q-u 1567 to 1928 362 to 1     Submitted on the opposite strand 362/362
(100 %)
1 diff
(99.8 %id)
BF741759 bocio_tumor .q-u 1567 to 1796 344 to 115     Submitted on the opposite strand 230/344
(66 %)
0 diff
(100 %id)
BF741769 bocio_tumor .q-u 1567 to 1880 1 to 317       317/317
(100 %)
6 diff
(98.2 %id)
BF741813 bocio_tumor .q-u 1567 to 1931 368 to 5     Submitted on the opposite strand 364/368
(98 %)
0 diff
(100 %id)
BF741821 bocio_tumor .q-u 1567 to 1936 369 to 1     Submitted on the opposite strand 369/369
(100 %)
4 diff
(99.0 %id)
BG980877 colon_normal .q-u 1567 to 1912 355 to 6       350/355
(98 %)
0 diff
(100 %id)
CV387369 bocio_tumor .q-u 1567 to 1753 187 to 1     Submitted on the opposite strand 187/187
(100 %)
1 diff
(99.5 %id)
CV387405 bocio_tumor .q-u 1567 to 1930 436 to 64     Submitted on the opposite strand 373/436
(85 %)
28 diff
(93.6 %id)
CV387429 bocio_tumor .q-u 1567 to 1808 246 to 5     Submitted on the opposite strand 242/246
(98 %)
0 diff
(100 %id)
CV387413 bocio_tumor .q-u 1573 to 2005 446 to 13     Submitted on the opposite strand 434/446
(97 %)
0 diff
(100 %id)
BF741032 bocio_tumor .q-u 1575 to 1914 29 to 366       338/366
(92 %)
0 diff
(100 %id)
BF907858 uterus_tumor .q-u 1592 to 2009 437 to 20     Submitted on the opposite strand 418/437
(95 %)
9 diff
(98.0 %id)
BF908486 uterus_tumor .q-u 1592 to 2009 437 to 20     Submitted on the opposite strand 418/437
(95 %)
9 diff
(98.0 %id)
BF740879 bocio_tumor .q-u 1605 to 2009 408 to 3     Submitted on the opposite strand 406/408
(99 %)
0 diff
(100 %id)
BF741773 bocio_tumor .q-u 1647 to 2000 1 to 354       354/358
(98 %)
7 diff
(98.1 %id)
CV387389 bocio_tumor .q-u 1659 to 2109 111 to 562   tiling clone,   452/562
(80 %)
0 diff
(100 %id)
BF740877 bocio_tumor .q-u 1686 to 2009 329 to 4     Submitted on the opposite strand 326/329
(99 %)
0 diff
(100 %id)
AL042051 testis .q-u 1724 to 1930 1 to 207       207/210
(98 %)
2 diff
(99.1 %id)
BF741026 bocio_tumor .q-u 1757 to 2009 256 to 3     Submitted on the opposite strand 254/435
(58 %)
0 diff
(100 %id)
AL039681 testis .q-u 1856 to 2234 1 to 379 M47I tiling clone,   379/379
(100 %)
2 diff
(99.5 %id)
CV387374 bocio_tumor .q-u 1884 to 2005 3 to 126       124/136
(91 %)
10 diff
(92.7 %id)
BG425063 Kidney, renal cell adenocarcinoma .r 1 to 335 1 to 335 exact tiling clone, AAA   335/705
(47 %)
5 diff
(99.3 %id)
AY927628   .s 1 to 1204 1 to 1258 exact tiling clone,   1258/1388
(90 %)
11 diff
(99.3 %id)
DA360854 subthalamic nucleus .t 1 to 554 2 to 555 exact tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
NM_001163423.1   .u 1 to 1025 1 to 1025 exact RefSeq, AAA   1025/1025
(100 %)
0 diff
(100 %id)
BM793208 Ascites, stomach .u 1 to 377 1 to 377   tiling clone,   377/377
(100 %)
2 diff
(99.5 %id)
GD153881   .va 1 to 176 999 to 825 L18P M20L N21L M22V C24Y ... tiling clone, Submitted on the opposite strand 175/999
(17 %)
0 diff
(100 %id)
AK026203 human small intestine Gene ZNF580andZNF581andCCDC106, variant not shown       available from FLJ, AAA Suspected internal deletion, this clone was ignored    
AL535601 brain, fetal brain Gene ZNF580andZNF581andCCDC106, variant not shown         This clone was ignored    
AL565985 brain, fetal brain Gene ZNF580andZNF581andCCDC106, variant not shown         This clone was ignored    
EC478675 Prostate Gene ZNF580andZNF581andCCDC106, variant not shown         Suspected internal deletion, this clone was ignored    
EC492735 Prostate Gene ZNF580andZNF581andCCDC106, variant not shown         Suspected internal deletion, this clone was ignored    
BP260549 small intestine Gene ZNF580andZNF581andCCDC106, variant not shown         Suspected internal deletion, this clone was ignored    
AA046275 heart Gene ZNF580andZNF581andCCDC106, variant not shown         Suspected internal deletion, this clone was ignored    
AA046359 heart Gene ZNF580andZNF581andCCDC106, variant not shown         Suspected internal deletion, this clone was ignored    
BQ183655 Knee, Osteoarthritic Cartilage Gene ZNF580andZNF581andCCDC106, variant not shown       AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k, .l, .m, .n, .o, .p-u, .q-u, .r, .s, .t, .u, .va Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI